• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Evaluation of Sensitivity and Specificity of Three Commercial Real-Time Quantitative Polymerase Chain Reaction Kits for Detecting SARS-CoV

tetano

Editor, Senior Moderator
Cureus


. 2021 Dec 22;13(12):e20627.
doi: 10.7759/cureus.20627. eCollection 2021 Dec.
Evaluation of Sensitivity and Specificity of Three Commercial Real-Time Quantitative Polymerase Chain Reaction Kits for Detecting SARS-CoV-2 in Bangladesh


Farzana Mim[SUP] 1 [/SUP], Md Selim Reza[SUP] 2 [/SUP], Mohammad Jahidur Rahman Khan[SUP] 3 [/SUP], Nurul Karim[SUP] 1 [/SUP], Mohammad A Rahman[SUP] 1 [/SUP], Md Ibrahim Hossain[SUP] 1 [/SUP], Rajib Biswas[SUP] 4 [/SUP]



Affiliations

Abstract

Background The coronavirus disease 2019 (COVID-19) pandemic has manifested into an unprecedented public health crisis. The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has facilitated reagent developers to customize and receive authorization for nucleic acid testing kits in a short period, which would have resulted in some shortcomings in the quality parameters of the kits. Consequently, in-house clinical validations of innovative real-time quantitative polymerase chain reaction (RT-qPCR) kits are required. This research aims to determine the sensitivity, specificity, and accuracy of various RT-qPCR kits available in Bangladesh. Methodology A total of 150 samples were obtained from patients with suspected COVID-19 infection when the delta variant was predominant, followed by RNA extraction performed using a nucleic acid isolation kit. Subsequently, three commercially available PCR kits named Sansure (China), STAT-NAT[SUP]Ⓑ[/SUP] (Sentinel Diagnostics, Italy), and Roche Biochem (Switzerland) were applied to detect SARS-CoV-2. Results The results showed that the STAT-NAT[SUP]Ⓑ[/SUP] kit is more sensitive than the other two, as indicated by the cycle threshold (Ct) values of respective genes. STAT-NAT[SUP]Ⓑ[/SUP] RT-qPCR can detect the ORF1ab gene sensitively (p < 0.001) compared to Sansure. STAT-NAT[SUP]Ⓑ[/SUP] was also capable of detecting E and RdRp genes more sensitively (p < 0.001) compared to Roche. Regarding specificity, STAT-NAT[SUP]Ⓑ[/SUP] (95% confidence interval [Cl] = 92.29-99.73%). RT-qPCR showed more accuracy than Sansure (95% Cl = 90.77-99.32%) and Roche (95% Cl = 81.17-94.38%). The area under the curve for E, ORF1ab, and RdRp genes of the STAT NAT[SUP]Ⓑ[/SUP] PCR kit was 0.952, 0.959, and 0.981, respectively. Conclusions This study concluded that STAT-NAT[SUP]Ⓑ[/SUP] is a better diagnostic RT-qPCR kit compared to Sansure and Roche for detecting SARS-CoV-2.

Keywords: covid-19; diagnostic performance; rt-qpcr; sars-cov-2; sensitivity; specificity.
 
Back
Top Bottom